TY  - JOUR
AU  - Guièze, Romain
AU  - Liu, Vivian M.
AU  - Rosebrock, Daniel
AU  - Jourdain, Alexis A.
AU  - Hernández Sánchez, María
AU  - Martinez Zurita, Aina
AU  - Sun, Jing
AU  - Hacken, Elisa Ten
AU  - Li, Shuqiang
AU  - Davids, Matthew S.
PY  - 2019
DO  - 10.1016/j.ccell.2019.08.005
SN  - 1535-6108
UR  - https://hdl.handle.net/20.500.14352/111182
T2  - Cancer Cell
AB  - Mitochondrial apoptosis can be effectively targeted in lymphoid malignancies with the FDAapproved B-cell lymphoma 2 (BCL-2) inhibitor venetoclax, but resistance to this agent is emerging. We show that venetoclax resistance in chronic lymphocytic...
LA  - eng
M2  - 369
PB  - Cancer Cell
TI  - Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
TY  - journal article
VL  - 36
ER  -